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Abstract 
Establishing a New Model of Endotoxemia-Associated Acute Kidney Injury in Zebrafish 
 
Adam Michael DeDionisio, MS 
 
University of Pittsburgh, 2020 
 
 
          Sepsis is a leading cause of in-hospital patient deaths and is characterized through a systemic 
inflammatory response and subsequent organ failures.  The kidney is known to be particularly 
susceptible to injury in this setting, with sepsis-associated acute kidney injury (S-AKI) being the 
most common organ dysfunction during sepsis.  Notwithstanding this prevalence, the general 
mechanisms which cause S-AKI are largely unknown.  Hypotheses regarding the roles of pro-
inflammatory molecular pathways and related cellular responses have been of interest to explain 
such pathological effects.  While recent studies have made strides to identify biomarkers of S-AKI 
from human patient data, and altered molecular pathways from animal and in vitro models, one 
source difficulty in making further progress are the model systems themselves.  Current model 
systems are rife with their own complications; many fail to mirror known human S-AKI 
pathologies, and many are either difficult to work with, or do not give consistent results from one 
assay to the next.  Here, we strove to develop a new in vivo model of S-AKI through 
microinjections of the endotoxin lipopolysaccharide from Pseudomonas aeruginosa into zebrafish 
larvae.  While much is to be learned from this model, early data suggests this system is efficient, 
easy to work with, consistent, and shows hallmarks of kidney dysfunction and proinflammatory 
responses post-injection.  As such, it may act as a valuable tool to understand the biopathology of 
S-AKI, as well as serve as a vital high throughput drug discovery model to identify novel 
therapeutics. 
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1.0 Background and Significance  
1.1 Sepsis as a Global Health Issue 
Then again the messenger Argeiphontes spake to him: “Old sire, not yet have dogs 
and birds devoured him, but still he lieth there beside the ship of Achilles amid the 
huts as he was at the first; and this is now the twelfth day that he lieth there, yet his 
flesh decayeth not at all. 
 
-Homer, The Iliad, Book 24 v.410-414 
 
For over 2,700 years, sepsis has been described and studied; the term’s first known usage—
found in the above verses—can be traced to Homer’s The Iliad, derived from the Greek verb sepo 
(σηπω), meaning “I rot”[1-3].  From Hippocrates to Semmelweis, from Koch to the current day, 
the general connotation of sepsis has been relatively unchanged, and though great strides have 
been made in the past few decades to research and treat this pernicious condition, there still remains 
a significant journey ahead to fully understand its pathology and to develop meaningful treatments 
and therapeutics for affected patients. 
In the United States, sepsis is the leading cause of in-hospital deaths and has an associated 
annual cost of over $24 billion[4, 5].  As the understanding of sepsis has evolved throughout the 
centuries, so have the medical definitions and classifications.  Most recently in 2016, the Third 
International Consensus Definitions (Sepsis-3) refined the general definition of sepsis as a life-
threatening condition of organ dysfunctions caused by an individual’s dysregulated infection 
response[6].  This definition arose through the study of large hospital patient cohorts and their 
associated clinical outcomes, as well as the current understandings of associated molecular and 
cellular mechanisms during disease progression.  Having empirical benchmarks for organ 
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dysfunctions following an infection-related inflammatory response improved upon previous 
definitions (i.e. systemic inflammatory response syndrome, SIRS)[7, 8].   
To estimate the global occurrence of sepsis, a team of researchers published an article in 
2016 which analyzed a large collection of data from 27 clinical studies over the preceding 36 years.  
This study estimated the annual global incidence of sepsis to be a staggering 31.5 million cases 
with around 5.3 million deaths[9].  Of note, these conclusions were based on data originating from 
seven high-income countries; to further gain insight into the occurrence of sepsis, Rudd et al. 
(2020) analyzed multiple cause-of-death databanks from low, middle, and high-income countries.  
With this data set and metanalyses, this study remarkably concluded that the reality of sepsis 
appears much more grim, estimating 48.9 million cases of sepsis/year and 11 million sepsis-related 
deaths/year[10].  In context, this astonishingly would account for nearly 20% of all deaths 
worldwide being related to sepsis.  The highest risk areas identified were low-income countries of 
sub-Saharan Africa and Southern/South-Eastern Asia.   
These studies paint a sobering reality of a world beset by this devastating condition, and 
though research has been laudatory over the past decades, remarkably there is still a void of 
targeted therapies to adequately address sepsis-associated organ dysfunctions.  As such, it is of 
importance to examine the current aggregate of knowledge on the initiation and progression sepsis, 
how this pathology is currently experimentally studied, and what data experimental model systems 
indicate as potential mechanisms for both causes of—and solutions to—organ dysfunctions. 
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1.2 Sepsis-Associated Acute Kidney Injury (S-AKI) Epidemiology and Pathobiology 
During sepsis, though acute kidney injury is the most frequent organ failure, exact 
mechanisms causing organ dysfunction are relatively unknown, nor have effective 
treatments/therapeutics been developed[11].  Such understandings and treatments are greatly 
needed as sepsis is the leading cause of AKI, and more specifically, patients who develop S-AKI 
have upwards of 5 times the mortality rate as sepsis patients without S-AKI[12, 13].  Recent studies 
have indicated that ~60-70% of patients with sepsis have AKI[12, 14], and importantly, patients 
who survive S-AKI face increased long-term health risks of chronic kidney disease (CKD) and 
end-stage renal disease (ESRD)[15-17].  
Through the studies of animal models, human patients, and septic human postmortem 
tissues, an initial picture of the pathobiology of S-AKI can be interpreted.  Surprisingly, neither 
animal models nor postmortem human kidney tissues have shown significant cellular necrosis—a 
form of cell lysis death due to external sources of injury—during  S-AKI, indicating that acute 
tubular necrosis is not a major factor contributing to loss of kidney functions in human patients[18-
21].  Similarly, apoptosis—a form of programmed cell death—of tubular cells does not seem to be 
a consistent nor attributable phenomena of S-AKI pathobiology, though the apoptosis of 
infiltrating leukocytes during S-AKI is notable[18, 19, 22, 23].   
Notwithstanding, patches of proximal tubule cells show a loss of brush border and apical 
vacuolization have been identified in human postmortem samples[19, 22].  Additionally, variable 
portions of proximal and distal tubules show dilation and cytoplasmic flattening[22]; all of which 
indicate significant functional changes to these cells.  Together, these observations suggest that 
during sepsis, renal epithelial cells may undergo molecular reprogramming to favor cell survival 
over organ function. 
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During sepsis, alterations in microcirculation and subsequent heterogeneous blood flow is 
known to occur through mechanisms such as inflammatory vasodilation, autoregulation, 
endothelial dysfunction, and activation of the coagulation cascade[24-26].  Such phenomena are 
still intense areas of study as to determine to what extent these occur in the kidney during S-AKI, 
and how they contribute to progressive kidney injury and failure. Recent studies of renal blood 
flow (RBF) (both in animal models and human patient studies) interestingly have demonstrated 
that homeostatic microcirculation can even be altered in the presence of normal or increased global 
RBF[20, 27, 28].  These seemingly contradictory facts could be explained by mechanisms such as 
endothelial dysfunction leading to vascular shunting, microthrombi formation (though this is rarely 
seen in human S-AKI patients), and interstitial edema via damage of the glycocalyx and increased 
vascular permeability[29-31].  These factors could contribute to some nephrons becoming 
hypoperfused, even as RBF appears normal.  Such alterations in microcirculation can be directly 
related to inflammatory cascades and the activities of the innate immune system during the 
infection response.  Histological analyses of human postmortem tissues demonstrate a massive 
infiltration of leukocytes into renal capillaries, glomeruli, and—less frequently—into tubular 
lumens during S-AKI[22].  Proinflammatory effects and other pathological consequences of 
leukocyte infiltrations are discussed in future sections. 
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1.3 Molecular Mechanisms and Cellular Responses of S-AKI Pathology 
1.3.1 Pattern Recognition Receptors and Their Agonists 
To properly treat and prevent life-threatening organ dysfunctions during sepsis, scientists 
and clinicians need to have a firm understanding of the various molecular mechanisms which 
contribute to the pathology.  Unfortunately, such mechanisms are not fully understood, and there 
are no proven therapeutics yet which can revive or regenerate organs in this state.  A primary 
hypothesis to address the phenomena of sepsis-associated organ dysfunction focuses on the 
exacerbated, systemic inflammatory responses following infection.  To identify and respond to 
pathogens, organisms throughout Eukarya have evolved a wide array of protein receptors to act as 
a first line of defense.  In the innate immune response, Pattern Recognition Receptors (PRRs) 
evolved for this function and have remained significantly conserved throughout the Animal 
Kingdom[32-34]. The PRR family largely consists of subgroups of the membrane-bound Toll-like 
receptors (TLRs) and C-type lectin receptors, and the intracellular cytoplasmic NOD-like receptors 
(NLRs) and RIG-I-like receptors (RLRs)[35-39].  The variety of PRRs was an evolved array of 
mechanisms so that organisms could properly identify and respond to specific pathogenic stimuli 
appropriately.   
Agonists of PRRs consist primarily of two classes of molecules: pathogen-associated 
molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), also known as 
danger-associated molecular patterns.  PAMPs are a wide variety of various molecular motifs 
which, when detected by PRRs, initiate host non-self signaling to respond to the presence of 
foreign microbes[40].  Examples of PAMPs include bacterial peptidoglycan, lipopolysaccharide 
(commonly referred to as ‘endotoxin’), lipoteichoic acid, and viral dsRNA[41-43].  DAMPs refer 
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to a class of non-infectious endogenous molecules released by damaged or dying cells and tissues 
which interact with PRRs to initiate inflammatory responses[44].  As such, they act as an alarm 
that nearby cells/tissues have been damaged in some capacity and require attention.  Examples of 
DAMPs include DNA (nuclear and mitochondrial), RNA, HMGB1, heat-shock proteins, and the 
extracellular matrix components hyaluronan and heparin sulfate[44-46].   
The interplay between PRRs and PAMPs/DAMPs is of primary interest in the case of 
sepsis to understand the initial spark that ignites a systemic host response.  Of importance in this 
setting are the TLRs, which can be found on the membranes of leukocytes, endothelial, epithelial, 
and fibroblast cells[47].  Within the PRR superfamily, there have been 10 identified TLRs in 
humans and 12 in mice, each with its own specialty for interacting with molecules particular to 
various pathogens[39, 48].  Many studies have examined the role of TLRs during infection and 
related sepsis, and while many can be active during these pathologies, TLR4 is of particular interest 
to address the molecular origins of systemic inflammation and subsequent organ dysfunctions[49-
54]. 
1.3.2 TLR4 Signaling 
TLR4 is a transmembrane receptor consisting of an extracellular leucine-rich repeat 
domain, and an intracellular toll/interleukin-1 receptor (TIR) domain[55].  A primary binding 
agonist of TLR4 is the gram-negative bacterial endotoxin lipopolysaccharide (LPS).  LPS 
molecules are large multicomplex molecules which are embedded within the outer membrane of 
gram-negative bacteria.  They consist of three major segments: the O-antigen, a glycan polymer 
and outer-most segment of LPS; the core oligosaccharide; and Lipid A, a phosphoglycolipid which 
anchors the whole complex into the membrane[56, 57].  During infection, hosts’ LPS-binding 
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proteins (LBP) bind to LPS in serum and transfers it to the extracellular membrane-bound CD14 
protein.  This further stimulates the formation of the TLR4/MD-2 heterodimer complex as LBP 
transfers LPS to Myeloid Differentiation Factor 2 (MD-2).  Of note, it is the lipophilic segment of 
LPS, Lipid A, that binds to MD-2[42, 58, 59].   Once this heterodimer complex is formed at the 
membrane, the signal is transferred intracellularly through two potential known pathways: the 
MyD88-dependent and -independent pathways.  During the MyD88-dependent pathway, the signal 
leads to a series of protein interactions which culminate in the activation of TAK1 as well as NF-
κB via the degradation of IκB.  Together, these lead to the activation of several mitogen-activated 
protein kinases (MAPK), the production of key proteins in inflammatory processes (e.g. COX-2 
and iNOS), and release of proinflammatory cytokines (notably TNF-α, IL-1β, and IL-6)[60-62].  
Importantly, secreted proinflammatory cytokines—such as TNF-α and IL-6—have been well 
studied to further activate NF-κB in an autocrine and paracrine fashion, thus contributing to a 
positive feedback of inflammatory responses[63, 64].  During the MyD88-independent pathway, 
the TLR4/MD-2 complex become internalized as an endosome.  Intracellularly, TLR4 binds to the 
adaptor proteins TRAM and TRIF, leading to the activation of IRF3/7.  This culminates in the late-
phase activation of NF-κB, as well as the expression of type-I interferons and cytokines, such as 
the chemoattractant CXCL10[50, 65].  Of note, TLR4 is also able to be activated via interactions 
with DAMPs, such as Hsp72[66] and HMGB1[67].  Figure 2 is a basic schematic of the TLR4 
pathway activation via LPS. 
1.3.3 Innate Immune Responses During Infection and Inflammation 
As said cytokines and chemoattractants are secreted by stimulated cells, the innate immune 
system mounts an initial response to infection.  Neutrophils are essential to combat pathogens as 
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they are the first immune cells to extravasate to sites of infection.  Once localized, neutrophils act 
to combat infection through ROS production, NO production via iNOS, the formation of neutrophil 
extracellular traps (NETs), cytokine production, and phagocytosis[68-70].  These immune cells 
are short-lived, and have been observed to undergo apoptosis/pyroptosis within 24 hours[71].  This 
massive death of neutrophils, along with death of pathogens and various host cells, releases 
substantial DAMPs which can further exacerbate inflammatory responses and cell stress[70].  
Moreover, NO is a potent vasodilator and contributes to lowering of blood pressure, and the 
cytokines produced by neutrophils adhere to endothelial cells to promote coagulation and 
thrombogenesis[31].  These effects are of significance as endothelial dysfunction and 
microcirculatory aberrations are well-established phenomena of sepsis[31, 72, 73]. 
   Various cytokines also influence and attract macrophages which are present at sites of 
infection shortly after the initial infiltration of neutrophils[74].  During initial stages, 
proinflammatory cytokines induce macrophage polarization to the M1 phenotype.  M1 
macrophages act to combat pathogens and further secrete proinflammatory molecules, again 
notably via the NF-κB pathway[74-76].  Though they play essential roles in neutralizing the 
presence of pathogens, it is to note that they perpetuate proinflammatory responses which can 
further a positive feedback loop of inflammation in a paracrine fashion.  The balance of their utility 
and detrimental effects during sepsis is not fully understood as more research is required.  The 
actions and pathological alterations of the adaptive immune system during sepsis, though 
interesting and worth exploring, are outside the scope of this review. 
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1.3.4 Further Consequences of LPS and Proinflammatory Responses 
Proinflammatory cytokines, such as TNF-α, have been documented to have further 
deleterious effects as they can increase the levels of reactive oxygen species (ROS) produced 
within cells[77, 78].  This rise in intracellular ROS induces mitochondrial dysfunction within cells, 
and can eventually lead to apoptosis[79-81].  The presence of ROS molecules, as well various 
PAMPs and DAMPs, have also been documented in the assembly and activation of the NLRP3 
inflammasome[82, 83].  The NLRP3 inflammasome is a multimeric protein complex which, once 
activated, is known to facilitate the activation of caspase-1, a potent inducer of pyroptosis cell 
death.  It also activates proinflammatory molecule IL-1β, and the pro-apoptosis molecule caspase-
8[82, 84, 85].  Pyroptosis has recently been identified as a key contributor to the pathogenesis of 
sepsis in the kidney and other tissues in mouse and zebrafish models[86-90]. 
As LPS induces a variety of inflammatory responses, cells struggle to maintain 
homeostasis.  By investigating particular downstream consequences post-TLR4 activation, several 
studies have identified significant increases in endoplasmic reticulum-stress (ER-stress), both in 
vitro and in vivo[91-93].   ER-stress is a product of the accumulation of mis-or-unfolded proteins 
within the ER, and this poses serious threats to cell function and survival.  If the ER sentinel 
proteins IRE1α , PERK, and ATF detect mis/unfolded proteins, the unfolded protein response 
(UPR) occurs[94].  This is a safety mechanism which increases the production of chaperone 
proteins, decreases overall RNA and protein production, and triggers cell cycle arrest[95].  
However, prolonged ER-stress—including stress induced via TLR4 activation—has been 
demonstrated to cause activation of the NLRP3 inflammasome, mitochondrial dysfunction, release 
of DAMPs, and apoptosis[91, 96, 97].  Interestingly, pharmacological inhibition of ER-stress via 
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4-phenylbutyrate significantly lowered inflammatory responses and tissue injury in an in vivo LPS-
induced mouse model, as well as an in vitro model with human epithelial cells[92].   
The deleterious effects of LPS on host cells and tissues extends further than known 
consequences of TLR4 activation.  A growing body of research, first described in 2012[98], has 
been the discovery and elucidation of the unique form of cell death known as ferroptosis.  
Ferroptosis is a consequence of cellular distress stemming from iron-dependent lipid peroxidation.  
This process forms reactive lipid species (RLS)—notably malondialdehyde (MDA) and 4-
hydroxy-2-nonenal (4-HNE)—which have been found as mediators of multiple pathologies such 
as stroke[99], intracerebral hemorrhage[100], acute kidney injury[101], lung fibrosis[102], cardiac 
ischemia-reperfusion injury[103], and sepsis[104-107].  In an interesting 2016 study, researchers 
investigated the effects of LPS on red blood cells (RBC)[108].  Utilizing toxic and non-toxic 
variants of LPS (which conversely act as TLR4 antagonists), they found that both strains were able 
to directly interact with RBC membranes and cause hemolysis.  This finding presents serious 
down-stream implications in pathogenesis.  When RBCs lyse, free hemoglobin is released into 
circulation which is able to permeate endothelial barriers and enter lymph fluids[109].  To prevent 
free iron-induced damage, organisms have evolved specific heme binding proteins such as 
haptoglobin and hemopexin[110].  However, satiation of such binding proteins during 
overwhelming hemolysis can lead to free iron injury and subsequent ferroptosis of affected cells; 
such a condition—for example—has been studied to understand the progression and evolved 
defenses to malaria infection[111].  Significant increases in cell-free hemoglobin during sepsis has 
been documented, and how this and ferroptosis relate to associated kidney/organ dysfunction is a 
burgeoning area of study[112-117].   
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1.3.5 S-AKI Biomarkers: IGFBP7 and TIMP-2 
As previously alluded to, it remains intriguing that initial kidney dysfunction can occur 
during sepsis with little-to-no histological aberrations[118].  As such, hypotheses regarding the 
prime causes of S-AKI began to focus on mechanistic changes within tubular cells to explain the 
initial loss of function.  In 2013, Kashani et al. published a study which examined the urine of 
septic patients who eventually developed AKI to find novel biomarkers[119].  Indeed, they 
discovered two biomarkers—insulin-like growth factor binding protein 7 (IGFBP7) and tissue 
inhibitor of metalloproteinases-2 (TIMP-2)—which together gave the best statistical power 
compared to other known biomarkers (e.g., NGAL, KIM-1, cystatin-C) to predict if a patient would 
develop S-AKI up to 48 hours before a loss of kidney function was clinically identified.   
The exact roles of these biomarkers during S-AKI are yet to be fully elucidated, however, 
two main aspects are worth noting.  Both IGFBP7 and TIMP-2 have several well documented 
functions, however they are both thought to enhance G1 cell cycle arrest during cell injury[119-
121].  There has been increasing evidence that cells (e.g. epithelial, renal tubular cells) go through 
transitions of cell cycle arrest and potential dedifferentiation during times of injury or stress.  Data 
suggest these are protective and regenerative mechanisms to weather temporary insults, and have 
been studied in the kidney during scenarios of ischemia[122], nephrotoxic injury[123], and 
sepsis[124].  Moreover, evidence not only suggests that cell cycle arrest and dedifferentiation 
during kidney injury are essential to healthy adaptive repair, but require precise regulation and 
timing post-injury to be effective[123, 125].  Another recent study investigated the role of TIMP-
2 during mouse models of S-AKI and cultured human kidney cells (HK-2) exposed to LPS.  
Findings indicated that TIMP-2 appears to associate with the NF-κB pathway, promoting the 
expression of proinflammatory cytokines.   In culture, the increase in proinflammatory cytokines 
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promoted apoptosis, and when TIMP-2 was knocked down via a lentiviral vector during an in vivo 
mouse S-AKI model, proinflammatory cytokines significantly decreased, measured kidney 
function increased, and histopathological alterations were noticeably less compared to 
controls[126].  Together, these studies of TIMP-2 and IGFBP7 paint an intriguing picture of their 
roles during S-AKI, however, a more complete understanding of their potential positive and 
negative functions during this pathology still require more investigations. 
1.3.6 Experimental Models of S-AKI 
Of critical importance in the scientific and clinical progress to understand S-AKI are the 
experimental models which serve as the basis of knowledge which will stem mechanistic 
understandings and effective treatments for patients.  While there have been several models of 
sepsis and S-AKI in a wide range of systems—such as porcine, ovine, and bovine—the three 
primary models which are in use and show unique promise are mouse, zebrafish, and human cell 
culture models.  Within these models, S-AKI phenotypes can be triggered by three general 
mechanisms: exposure to an exogenous toxin (e.g. LPS), exposure to exogenous bacteria, or 
exposure to intrinsic microbes through surgical perforations of tissues[127].   
Mouse models of S-AKI have utilized all three said modes throughout the past decades, 
though the cecal-ligation and puncture (CLP) has emerged as a leading system.  The mouse CLP 
procedure consists of surgically perforating the cecum, causing endogenous bacterial flora to enter 
the body cavity[128].  This model system exposes the mouse to a wide range of microbes and can 
mimic known human S-AKI pathobiologies such as leukocyte infiltrations/apoptosis, systemic 
inflammatory responses, hemodynamic alterations, and various organ injuries/failures[129-131].  
This model system has some drawbacks, however, as researchers are unable to fully control the 
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specific types and amounts of bacteria per subject, organ dysfunctions—or lack thereof—can be 
highly variable, and there is a high mortality rate in a short period of time (~70-80% mortality after 
48 hours is common)[132].   
Zebrafish models of endotoxemia, sepsis, and S-AKI have been emerging as well as unique 
and valuable model systems.  By 48 hours post-fertilization, the zebrafish pronephros is functional; 
moreover, cell types and functions of the nephron are conserved compared to mammalian 
counterparts[133].  Additionally, the zebrafish adaptive immune system does not develop until 4 
weeks post-fertilization, allowing researchers to utilize zebrafish larvae to investigate sole roles of 
the innate immune system within various models[134].  A key difference in zebrafish nephrons 
compared to those of mammalian organisms is their intrinsic ability to fully regenerate and even 
form new nephrons after injury[135, 136]. This presents a unique model to investigate mechanisms 
of healing and regeneration post-injury, as well as given the ability to use large numbers of animals 
which are ideal for drug-discovery experiments[123, 137, 138].  Philip et al. (2017)[139] detail a 
zebrafish sepsis model via exposure to LPS in solution.  Compared to known human pathobiology, 
their model system demonstrated parallel sepsis phenotypes such as edema, organ injury, 
endothelial dysfunction, proinflammatory responses, increased ROS production, and immune cell 
activation.  Wen et al. (2018)[140] developed a model system that more specifically analyzed S-
AKI via microinjections of the known fish pathogen Edwardsiella tarda.  This model system 
demonstrated edema, proinflammatory responses, expression of known kidney injury biomarkers, 
and increased expression of IGFBP7 and TIMP-2 within tubule cells.  Additional specific 
examples of zebrafish and mouse models and related findings regarding S-AKI are detailed 
throughout previous sections.  More thorough suggested reviews of S-AKI animal models include 
Doi et al. (2009)[127] and Dejager et al. (2011)[132].  
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The use of human cell cultures is another vital tool, allowing the ability to study human 
cell-specific responses in sepsis modeling.  As such, utilizing cells of human origin may provide a 
greater potential to understand human-specific phenomena during sepsis as well as for applicable 
drug screenings to assay utility and toxicity.  In 1994, Ryan et al. generated the immortalized 
human proximal tubule epithelial cell line (HK-2) which is still utilized in modeling of 
sepsis/endotoxemia[141].  Examples of S-AKI research using HK-2 cells include the study of 
proinflammatory signaling, apoptosis, roles of lncRNAs/miRNAs, metabolomics, and injury 
responses, among others[142-147].  In addition to HK-2 cells, the use of primary human cell 
cultures is also being utilized in some research.  Donated human kidney tissues are dissociated to 
isolate particular cell types—such as glomerular, proximal tubule, and distal tubule—and are 
subsequently cultured and used for experiments.  As mutations and genetic drift can occur in HK-
2 cell lines after repeated passages, the use of primary cells presents a unique culture of cells 
directly from recently functioning human kidneys.  Exemplarily, Emlet et al. (2017) dissociated 
human kidneys and cultured separately cells of proximal or distal tubule origin to identify 
differences in cell-specific expression of kidney injury biomarkers IGFBP7 and TIMP-2[143].  
Figures 1-3 are schematics which combine knowledge gained from years of research which 
illustrate important molecular and cellular responses during sepsis. 
  
 15 
1.3.7 Schematics of Known S-AKI Molecular and Cellular Phenomena 
 
Figure 1: PAMP/DAMP renal cellular effects during endotoxemia.  A) Initial phase of endotoxemia as 
circulating PAMPs first cause expression and release of proinflammatory cytokines from host cells.  
Neutrophils first localize to the kidney and extravasate from peritubular capillaries to enter the proximal 
tubule.  Macrophages infiltrate typically after 24 hours.  B) During S-AKI, endothelial cell dysfunction leads 
to increased permeability between cellular junctions, allowing circulating cytokines, DAMPS, ROS, and 
various circulating molecules to seep through into interstitial space.  Leukocytes (primarily neutrophils and 
macrophages) undergo apoptosis, releasing more DAMPs and proinflammatory cytokines.  LPS is also 
known to cause red blood cell lysis, releasing cell-free iron into circulation.  Proximal tubule cells become 
vacuolized and their functions decrease, contributing to renal injury and failure. 
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 Figure 2: Schematic of TLR4 Activation via LPS.  In serum, LPS is bound by lipopolysaccharide binding 
protein (LBP).  LPS is transferred to CD14 at the cell surface, followed by its transfer to the TLR4/MD-2 
complex.  CXCR4 is known to cluster at this complex and may act to dampen downstream signaling.  After 
LPS binding with the TLR/MD-2 complex, the signal can progress through either the MyD88-dependent or the 
MyD88-independent pathway. 
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Figure 3: Intracellular signaling during endotoxemia.  TLR4 is activated by LPS and DAMPs, causing 
proinflammatory pathways to become active.  Various cell stresses caused by proinflammatory cytokines, 
PAMPs, and DAMPs contribute to ER stress, mitochondrial dysfunction, formation of the NLRP3 
Inflammasome, and activation/release of TIMP-2.  Consequentially, these factors can directly cause various 
cell cycle arrest, apoptosis, and pyroptosis.  Cell-free iron, which is significantly increased in the serum during 
sepsis, causes lipid peroxidation and ferroptosis. 
 
1.4 Creating a New Endotoxemia-Associated Acute Kidney Injury Model in Zebrafish 
In 2018, Wen et al. [140] published a model of S-AKI in zebrafish via live microinjections 
of the fish pathogen Edwardsiella tarda.  As previously mentioned, this model displayed mild 
edema, increased kidney injury makers, and expression of TIMP-2 and IGFBP7 within tubule cells 
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post-infection.  While this model displays known pathogenic features of S-AKI, working E. tarda 
in our lab proved to have many difficulties.  Results were highly variable from assay-to-assay, and 
zebrafish displayed little intermediate phenotypes; “sick” zebrafish progressed and died quickly, 
while the remainder displayed no signs of infection or sepsis.  Additionally, E. tarda is a highly 
virulent fish pathogen, thus presenting a challenging situation while working closely with a large 
zebrafish facility.  As such, we began to develop a new model of S-AKI without the use of live 
pathogens.  Zebrafish were to be used as they have several desirable characteristics as a model 
system that would be of use in this setting.  As they can be bred in large numbers, and their 
pronephros are functional within days, this model system allows for high throughput screening of 
both phenotypes, study of pathological molecular mechanisms, and eventually for drug discovery 
experiments.   
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2.0 Results and Discussion 
2.1 Sterile Edwardsiella tarda Microinjections 
Using the E. tarda model of S-AKI in zebrafish, attempts were made to kill the bacteria to 
assess the ability of a sterile injection to cause S-AKI phenotypes (e.g., edema) and mortality.  An 
initial attempt utilized a heat-kill method, either with or without subsequent sonication to further 
shred bacterial cells.  Various concentrations of bacteria were tested by measuring the optical 
densities (OD) prior to heat-killing.  Tested OD levels ranged from 1-5; with an OD of 2.5 equating 
to ~300 colony forming units per nanoliter (the amount injected in the established E. tarda 
microinjection protocol).  One nanoliter of each respective solution was microinjected into the 
sinus venosus of anesthetized zebrafish larvae on day 3 post-fertilization.  No solution nor method 
attempted caused any edema nor death after microinjections compared to controls (Table 1). 
Addressing the possibility that heating/sonicating caused significant denaturing of 
endotoxins, another set of experiments sought to create a sterile injection model without the use 
of excessive heat generation.  Similarly, E. tarda cultures were grown and concentrated to various 
ODs (1-5) for freeze-fracturing.  Samples were subjected to series of freeze/thaw cycles in liquid 
nitrogen, and one nanoliter of each respective solution was microinjected into the sinus venosus 
of anesthetized zebrafish larvae on day 3 post-fertilization.  No solution resulted in the 
development of edema nor caused death after microinjection compared to controls (Table 1) 
A further experiments utilized antibiotics to kill E. tarda bacteria prior to injection.  Two 
common Gram-negative susceptible antibiotics were tested: streptomycin (a protein synthesis 
inhibitor) and meropenem (an inhibitor of cell wall synthesis).  Minimum inhibitory concentrations 
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(MIC) of each antibiotic were identified previously (data not shown) and used in each experiment.  
E. tarda cultures were grown and concentrated to various ODs (2-5) and subsequentially treated 
with a respective antibiotic.  One nanoliter of each respective solution was microinjected into the 
sinus venosus of anesthetized zebrafish larvae on day 3 post-fertilization.  No solution resulted in 
the development of edema nor caused death after microinjection compared to controls (Table 1).  
For all sterile-based injection experiments, bacterial death was validated through plating of each 
solution on Tryptic Soy Agar plates with an overnight incubation at 28.5°C. 
2.2 PAMP and DAMP Microinjections with Negative Results 
 
Direct microinjections of multiple PAMP and DAMP molecules into day 3 post-
fertilization zebrafish were attempted to elicit potential renal dysfunction.  Post-injection, zebrafish 
were monitored for several days for signs of edema, death, or other overt phenotypes.  Several 
compounds were tested—each at least twice—and all of which showed negative results.  These 
included microinjections of: 20, 10, 5, and 1 ng of lipopolysaccharide from Escherichia coli (E. 
coli) dissolved in PBS; 20, 10, 5, and 1 ng of lipopolysaccharide from Escherichia coli (E. coli) 
dissolved in stearic acid; 1-2 nanoliters of 50, 10, and 1uM Lipid A; 1-2 nanoliters of 2,000, 200, 
100, 10, and 1uM Lipoteichoic acid (LTA) from Staphylococcus aureus; 1 nanoliter of 500, 250, 
100, 50 uM hemin; and 1-2 nanoliters of a 500uM hemin + 10ng/nl E. coli LPS solution (Table 1). 
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Table 1: Failed S-AKI/Endotoxemia Model Systems.  A brief synopsis of the various chemicals/solutions 
which failed to produce evidence of S-AKI/Endotoxemia post-microinjection into zebrafish larvae.  Tested 
concentrations for each is noted, and each experiment was attempted at least twice. 
 
  
 Method Doses Tested 
Endotoxins: LPS (E. coli) Injections 20, 10, 5, 1ng 
 LPS (E. coli) Micells Injections 20, 10, 5, 1ng 
 Lipid A Injection 50, 10, 1uM 
 Lipoteichoic Acid Injection 2mM, 200, 100, 10, 1 uM 
   
"Sterile" Bacterial-Based: 
Antibiotic Killed E. tarda 
(streptomycin/meropenem) 
4, 3, 2 OD 
 Heat-Killed E. tarda 4, 3, 2, 1 OD 
 Sonicated E. tarda 4, 3, 2 OD 
 Heat-Killed+Sonicated E. tarda 5, 4, 3, 2, 1 OD 
 Freeze Fractured E. tarda 5, 4, 3, 2, 1 OD 
   
DAMP: Hemin Injections 500, 250, 100, 50uM 
   
DAMP + PAMP Hemin+LPS (E. coli) 
Hemin: 500, 250uM + 
LPS: 20, 10ng 
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2.3 Microinjections of Lipopolysaccharide Derived from Pseudomonas aeruginosa 
An initial soak experiment was conducted to validate the toxicity of LPS derived from 
Pseudomonas aeruginosa with or without AMD3100, a chemical inhibitor of CXCR4.  High 
concentrations of LPS (100ug/ml), with or without AMD3100 (10ug/ml), were fatal after 24 hours.  
A lower concentration of 10ug/ml LPS showed mortality only when combined with AMD3100 
(Figure 3A). 
In several subsequent experiments, day 3 post-fertilization zebrafish were microinjected 
with Pseudomonas aeruginosa LPS into the sinus venosus and monitored for several days (Figure 
3B).  An initial set of experiments investigated the survival and edema phenotypes of the fish after 
multiple days post-injection.  Injections of 40 and 60ng LPS caused edema to varying extents, both 
with and without AMD3100 (Figure 3C, 3D).  Additionally, LPS injections caused mortality in all 
groups when tracked for 5 days post-injection (Figure 3E).  Control groups injected with PBS 
displayed no edema, nor mortality over this time frame.  Statistically, a survival assay calculating 
the area under the curve via a Kaplan-Meier analysis yielded 500, 441.7, 458.3, 452.1, 461.7 
arbitrary units (a.u.) for control, 40ngLPS, 40ngLPS + AMD3100, 60ngLPS, and 60ngLPS + 
AMD3100, respectively.  Data did not reach statistical significance when comparing treatment 
groups (dosage and AMD3100 treatment).  However, there was statistical significance comparing 
the control group to each treatment group: 40ngLPS, 40ngLPS + AMD3100, 60ngLPS, and 
60ngLPS + AMD3100; p = 0.001, p = 0.005, p = 0.0046, p = 0.0004, respectively.  As such, future 
experiments no longer included AMD3100 treatments. 
To validate if the LPS injections were causing an innate immune response, Tg(TNF-
α:GFP) zebrafish were injected.  Within 24 hours, significant expression of TNF-α was increased 
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compared to control injected zebrafish (Figure 4A), demonstrating the activation of pro-
inflammatory signaling pathways known to be linked to innate immune cells during endotoxemia.   
To ascertain possible kidney dysfunction contributing to the pathology, a set of day 3 post-
fertilization zebrafish were microinjected with 80ng LPS along with a control group injected with 
PBS.  At 48 hours post-injection, zebrafish were fixed and subsequently stained for Na+/K+-
ATPase.  Under healthy conditions, this ion channel is primarily found concentrated on the 
basolateral membrane of renal tubule cells, however during renal dysfunction, it becomes diffuse 
through the cytoplasm, losing its polarity.  Confocal analysis revealed that most LPS-injected 
zebrafish showed this loss in polarity in contrast to controls (Figure 4B). 
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Figure 4: Pseudomonas aeruginosa LPS Experiments. A) Survival of zebrafish larvae during a soak experiment 
with LPS +/- AMD3100. 15 fish per condition were tested. B) Schematic of zebrafish anatomy in relation to 
microinjection experiments, along with respective timeline.  C) Survival of zebrafish larvae after 
microinjections of LPS, +/- AMD3100 incubations.  Data represents 24 zebrafish per condition; survival of 
PBS-injected controls was 100% over the timecourse.  There was no statistaically significant difference in 
survival between the injected groups based on dose nor with AMD3100 treatment.  Significance did exist 
between each group and control, however (40ngLPS, 40ngLPS + AMD3100, 60ngLPS, 60ngLPS + AMD3100; 
p=0.001, p=0.005, p=0.0046, p=0.0004, respectively)  D) Images taken at 48hpi; array of edema phenotypes seen 
after LPS microinjections. E) Proportion of edema phenotypes from 24-72hpi of LPS. Data represents 24 
zebrafish per condition tested.   
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Figure 5: Inflammatory response and kidney injury post LPS microinjections. A) Brightfield/GFP 
representative images of Tg(TNF-a:GFP) zebrafish 24hpi with LPS.  B) Na+/K+ ATPase stain of zebrafish 
pronephros, 48hpi with LPS. 
2.4 Discussion 
As previously detailed, zebrafish model systems have unique characteristics which make 
them of interest to study the progression of endotoxemia and sepsis-associated kidney injury.  
However, there have been few developed models of endotoxemia/S-AKI which are consistent and 
reliably parallel to known human pathologies.  For example, while the zebrafish S-AKI model 
utilizing live E. tarda microinjections does show known hallmarks of the disease, it is highly 
variable, and overloading zebrafish with a virulent pathogen does not replicate what is seen in 
human patients.  Moreover, it is difficult to conclude exact mechanisms of kidney injury in the 
background of overwhelming infection.  With these factors in mind, we determined to establish a 
novel model system which overcame these critiques.   
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While multiple attempts failed to generate noteworthy phenotypes nor death, we eventually 
experimented with LPS extracted from Pseudomonas aeruginosa.  Zebrafish are known to have 
evolved tolerances to many endotoxins, however, a study by Novoa et al. (2009) found that LPS 
from Pseudomonas was able to cause inflammatory responses and mortality in zebrafish[148].  
These responses were amplified in the presence of AMD3100, a CXCR4 inhibitor, which is 
hypothesized to aggregate with TLR4 at the membrane and dampen downstream signaling.  This 
compound was utilized at first in attempt to replicate data of Novia et al. (2009) (Figure 3A), 
however, further experiments of LPS microinjections did not find significant differences to 
mortality nor edema with AMD3100 treatment (Figures 3B and 3D).  As such, AMD3100 use was 
not continued throughout further experiments.  An initial experiment in which Tg(TNF-a:GFP) 
zebrafish were injected demonstrated the obvious activation of proinflammatory pathways due to 
LPS exposure.  Further experiments should elucidate a more definite timeline of these 
proinflammatory pathways, and exactly which immune cells over this timeframe contribute to the 
inflammatory response.   
Monitoring of the zebrafish for several days after LPS injections indicated the progression 
of edema and mortality.  Edema can be caused by multiple sources of tissue injury; however, 
kidney dysfunction is a well-known cause of this phenotype.  Depending on the concentration of 
LPS, this model system was found to cause around 25-50% of injected zebrafish to develop edema.  
This edema typically became more pronounced over several days following the experiment, 
typically causing death of the zebrafish.   
To further provide insight into the possibility of kidney dysfunction within this model 
system, a Na+/K+ ATPase stain was performed on zebrafish 48 hours post-injection.  Tubules of 
LPS-injected zebrafish notably lost polarization of this ion channel, with its expression being 
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primarily diffused throughout the cytosol.  This observation contrasted with zebrafish control 
subjects which showed strong basolateral localization.  Overall, this provides preliminary evidence 
that renal tubule cells are truly in a state of stress and dysfunction in response to LPS.  
2.5     Future Directions and Conclusion 
 Future experiments should start by further characterizing this pathology through studying 
the time course of kidney dysfunction by viewing changes in kidney injury biomarkers, 
proinflammatory pathways, and cellular stress biomarkers.  These studies should assess the 
pathology at the levels of RNA, protein, functionality, and histology.   
Once a deeper understanding of this model system arises, it can serve as a platform to 
investigate the molecular pathobiology of S-AKI/Endotoxemia as there is still much unknown to 
explain the mechanisms of kidney injury in these settings.  For example, the role of biomarkers 
TIMP-2 and IGFBP7 can be further explored, as can their role in cell cycle arrest, their interactions 
with inflammatory pathways, and their relationships with kidney dysfunction.  Additionally, the 
exact cellular consequences of the proinflammatory response—initiated by TLR4—can be 
elucidated during kidney dysfunction.  Along with this topic, the study of the innate immune 
system during S-AKI could be explored.  The roles of neutrophils and macrophages—for better 
and for worse—could be investigated during a time course of injury and organ dysfunction.  As 
these cells act to initiate and perpetuate the inflammatory response, their overall contribution may 
be deleterious to renal function.  Discovering if/when the cluster around the pronephros, and how 
this affects kidney function are worthwhile areas to investigate.     
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If fortuitous, and the model does truly offer a window into this pathology, it may uniquely 
lend itself to the testing of novel therapeutic compounds to reverse injury and promote 
regeneration.  This is a key strength of a zebrafish model as a high throughput system.  Future 
experiments will help establish the molecular mechanisms of S-AKI, and how it may be possible 
for therapeutics to intervene during endotoxemia to prevent kidney dysfunction.  As there is much 
to understand regarding S-AKI pathology, this model system could serve to address multiple 
pathways, interactions, and cellular responses.  Indeed, this could even serve to study multiple 
organ dysfunctions during endotoxemia; the value of which is immeasurable given how grave a 
reality sepsis is, and how far we must go to develop meaningful and significant treatments.  A first 
step in this process is to have the tools necessary to test these questions, of which a reliable model 
system will serve as the bedrock.   
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3.0 Methods 
3.1 Zebrafish Husbandry and Microinjections 
All studies were approved by the University of Pittsburgh IACUC, and zebrafish were 
maintained as per published guidelines[149].  Zebrafish were incubated in E3 medium (5 mM 
NaCl, 0.17 mM KCl, 0.33 mM CaCl2, and 0.33 mM MgSO4, buffered to pH 7.2 with 10 mM 
HEPES); eggs/larvae were incubated in E3 medium-0.01 mg/l methylene blue (Sigma-Aldrich) up 
to 72 hours post-fertilization. Throughout experiments, tricaine (Sigma-Aldrich, MS-222) in E3 
medium was used for anesthesia (0.168 mg/ml), and for euthanasia (0.64 mg/ml).  Day 3 post-
fertilization larvae were microinjected with 1-2 nl of respective solutions in the sinus venosus as 
per previously published protocol[150].  PAMP/DAMP molecules injected included: Lipid A 
(Sigma-Aldrich, L5399), E. Coli LPS (Sigma-Aldrich, L2630), lipoteichoic acid (Sigma-Aldrich, 
L2515), P. aeruginosa LPS (Sigma-Aldrich, L9143), and Hemin (Sigma-Aldrich, H9039), all 
reconstituted as per manufacture guidelines.  For relevant experiments, AMD3100 (Sigma-
Aldrich, 239820) was used at 10µg/ml in E3. 
 
3.2 Na+/K+-ATPase Staining 
At 48 hours post-injection, zebrafish were euthanized, fixed, embedded in JB-4 resin 
(Polysciences, 18570-1), and stained with monoclonal Na+/K+ ATPase antibody (α-6F, 
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Developmental Studies Hybridoma Bank, Iowa) at 1:25 dilution, and secondary antibody goat anti-
mouse cy3 (Jackson Laboratories, 155-165-003) diluted 1:500 as per published protocol[150].  
Embedded zebrafish were sectioned on microtome (Shandon Finesse Thermo microtome) and 
examined by confocal microscopy (Zeiss LSM 700). 
 
3.3 Bacterial Culture 
Edwardsiella tarda (Ewing and McWhorter O1483:H1; ATCC 15947; American Type 
Culture Collection) was cultured in Tryptic Soy Broth (Sigma-Aldrich, 22092) at 28.5°C overnight 
while shaking while following published protocol[140].  Prior in injections, bacteria samples were 
resuspended in PBS to desired concentrations as determined by a spectrophotometer. 
 
3.4 Bacteria Heat Kill, Sonication, Freeze-Fracture, and Antibiotic Incubations 
To heat kill, bacterial cultures were placed in a dry bath incubator (Boekell Scientific) set 
to 65°C for 30 minutes.  A sonicator (Branson Digital Sonifier) was set to 20% intensity, and 
bacterial samples were sonicated for 30 seconds with 5 second on/off pulses.  Freeze-fractured 
bacterial samples were subjected to three freeze/thaw cycles by being submerged in liquid nitrogen 
for 30 seconds, followed by 5 minutes at room temperature.  For antibiotic-kill bacteria 
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experiments, bacterial cultures were incubated in respective antibiotics (meropenem, Sigma-
Aldrich, M2574; streptomycin, Sigma-Aldrich, P4333) for two hours prior to injections. 
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